World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
49
Citations
33996
World Ranking
4288
National Ranking
1949

Best Publications

  • Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

    Fernando P. Polack;Stephen J. Thomas;Nicholas Kitchin;Judith Absalon

  • Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.

    Edward E. Walsh;Robert W. Frenck;Ann R. Falsey;Ann R. Falsey;Nicholas Kitchin

  • COVID-19 vaccine BNT162b1 elicits human antibody and T H 1 T cell responses.

    Ugur Sahin;Alexander Muik;Evelyna Derhovanessian;Isabel Vogler

  • Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults.

    Mark J. Mulligan;Kirsten E. Lyke;Nicholas Kitchin;Judith Absalon

  • Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants.

    Unknown

  • Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.

    Robert W Frenck;Nicola P Klein;Nicholas Kitchin;Alejandra Gurtman

  • BNT162b vaccines protect rhesus macaques from SARS-CoV-2.

    Annette B. Vogel;Isis Kanevsky;Ye Che;Kena A. Swanson

  • Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera

    Unknown

  • Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.

    Unknown

  • Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.

    Emmanuel B. Walter;Kawsar R. Talaat;Charu Sabharwal;Alejandra Gurtman

  • Neutralizing Activity of BNT162b2-Elicited Serum.

    Yang Liu;Jianying Liu;Hongjie Xia;Xianwen Zhang

  • Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera.

    Xuping Xie;Yang Liu;Jianying Liu;Xianwen Zhang

  • Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera.

    Alexander Muik;Ann-Kathrin Wallisch;Bianca Sänger;Kena A. Swanson

  • SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3.

    Ann R Falsey;Robert W Frenck;Edward E Walsh;Nicholas Kitchin

  • BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants.

    Jianying Liu;Yang Liu;Hongjie Xia;Jing Zou

  • Neutralization of BA.4–BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent Vaccine

    Unknown

  • Neutralization and durability of 2 or 3 doses of the BNT162b2 vaccine against Omicron SARS-CoV-2

    Unknown

  • Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study.

    Unknown

  • Bivalent Omicron BA.1–Adapted BNT162b2 Booster in Adults Older than 55 Years

    Unknown

  • RNA-based COVID-19 vaccine BNT162b2 selected for a pivotal efficacy study

    Edward E. Walsh;Robert Frenck;Ann R. Falsey;Nicholas Kitchin

Frequent Co-Authors

Philip R. Dormitzer
Philip R. Dormitzer Pfizer (United States)
Kathrin U. Jansen
Kathrin U. Jansen Pfizer (United States)
Ugur Sahin
Ugur Sahin Johannes Gutenberg University of Mainz
Pei-Yong Shi
Pei-Yong Shi GlaxoSmithKline (United Kingdom)
David A. Cooper
David A. Cooper University of New South Wales
William C. Gruber
William C. Gruber Pfizer (United States)
Özlem Türeci
Özlem Türeci BioNTech (Germany)
Xuping Xie
Xuping Xie The University of Texas Medical Branch at Galveston
Ann R. Falsey
Ann R. Falsey University of Rochester
Jing Zou
Jing Zou The University of Texas Medical Branch at Galveston

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Kena A. Swanson

Recently Published Articles